Login Register Cart 0
Generic placeholder image

Current Diabetes Reviews

Editor-in-Chief

ISSN (Print): 1573-3998
ISSN (Online): 1875-6417

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Prevalence of Metabolic Syndrome and Its Associated Potential Factors among the Elderly in the East of Iran

Author(s): Toba Kazemi, Bita Bijari, Farshad Sharifi, Mitra Moodi, Farhad Saeedi, Saeede Khosravi Bizhaem, Fatemeh Hoseinzadeh-Chahkandak, Saeed Samarghandian and Tahereh Farkhondeh*

Volume 19, Issue 3, 2023

Published on: 02 August, 2022

Article ID: e060622205661 Pages: 9

DOI: 10.2174/1573399818666220606143934

Price: $65

Abstract

Background and Aims: This cross-sectional study aimed to determine potential factors with a strong association with metabolic syndrome (MetS) among obesity and lipid-related parameters, and liver enzymes, fasting blood glucose (FBG), and blood pressure (BP) as well as some sociodemographic factors in elderly over 60 years old from a sample of Birjand Longitudinal Aging Study (BLAS).

Methods: A total of 1366 elderly Birjand participants were enrolled and divided into non-MetS (n = 512) and MetS (n = 854) groups based on the status of MetS from January 2018 to October 2018. The anthropometric parameters, blood lipid profiles, liver enzymes, and disease history were evaluated and recorded.

Results: 62.5% of the participants from our sample of elderly Birjand have MetS (33.4% in males and 66.6% in females). The prevalence of MetS in females was significantly higher than in males (P < 0.001). The increasing trend in the number of MetS components (from 0 to 5) was observed in females (p < 0.001). Odds ratio showed a strong association between female gender [8.33 (5.88- 11.82)], obesity [8.00 (4.87-13.14)], and overweight [2.44 (1.76-3.40)] with MetS and acceptable association between TG/HDL [(1.85 (1.62-2.12)] with MetS.

Conclusion: This study indicated that the female sex, overweight and obesity have a strong association with MetS and TG/HDL has an acceptable association found in the sample of the elderly Birjand population. However, due to the obvious limitations of our study including the homogeneous sex and race of population, and no adjustment for several important confounding factors including sex, different ages, stage in the elderly, alcohol consumption, smoking, married status, physical activity, diet, and family history of CVD, more epidemiological investigations are needed to address this question.

Keywords: Metabolic syndrome, obesity, and lipid-related parameters, blood pressure, fasting blood glucose, elderly.

[1]
Bovolini A, Garcia J, Andrade MA, Duarte JA. Metabolic syndrome pathophysiology and predisposing factors. Int J Sports Med 2021; 42(3): 199-214.
[http://dx.doi.org/10.1055/a-1263-0898] [PMID: 33075830]
[2]
Lu MC, Chen IJ, Hsu LT, et al. Metabolic risk factors associated with chronic kidney disease in a middle-aged and elderly Taiwanese population: A cross-sectional study. Front Med (Lausanne) 2021; 8748037
[http://dx.doi.org/10.3389/fmed.2021.748037] [PMID: 34869437]
[3]
Yu J, Yi Q, Hou L, et al. Transition of lipid accumulation product status and the risk of type 2 diabetes mellitus in middle-aged and older Chinese: A national cohort study. Front Endocrinol (Lausanne) 2021; 12770200
[http://dx.doi.org/10.3389/fendo.2021.770200] [PMID: 34899605]
[4]
Finelli C. Metabolic syndrome, Alzheimer’s disease, and Covid 19: A possible correlation. Curr Alzheimer Res 2021; 18(12): 915-24.
[http://dx.doi.org/10.2174/1567205018666211209095652] [PMID: 34886772]
[5]
Wan X, Jia W, Zhuang P, et al. Associations of 3-monochloropropane-1,2-diol and glycidol with prevalence of metabolic syndrome: Findings from lanxi nutrition and safety study. Environ Res 2022; 209112746
[http://dx.doi.org/10.1016/j.envres.2022.112746] [PMID: 35063427]
[6]
Moore JX, Chaudhary N, Akinyemiju T. Metabolic syndrome prevalence by race/ethnicity and sex in the United States, national health and nutrition examination survey, 1988-2012. Prev Chronic Dis 2017; 14E24
[http://dx.doi.org/10.5888/pcd14.160287] [PMID: 28301314]
[7]
Delavari A, Forouzanfar MH, Alikhani S, Sharifian A, Kelishadi R. First nationwide study of the prevalence of the metabolic syndrome and optimal cutoff points of waist circumference in the Middle East: The national survey of risk factors for noncommunicable diseases of Iran. Diabetes Care 2009; 32(6): 1092-7.
[http://dx.doi.org/10.2337/dc08-1800] [PMID: 19279302]
[8]
Butler J, Rodondi N, Zhu Y, et al. Metabolic syndrome and the risk of cardiovascular disease in older adults. J Am Coll Cardiol 2006; 47(8): 1595-602.
[http://dx.doi.org/10.1016/j.jacc.2005.12.046] [PMID: 16630996]
[9]
Azizi F, Salehi P, Etemadi A, Zahedi-Asl S. Prevalence of metabolic syndrome in an urban population: Tehran lipid and glucose study. Diabetes Res Clin Pract 2003; 61(1): 29-37.
[http://dx.doi.org/10.1016/S0168-8227(03)00066-4] [PMID: 12849921]
[10]
Srikanthan K, Feyh A, Visweshwar H, Shapiro JI, Sodhi K. Systematic review of metabolic syndrome biomarkers: A panel for early detection, management, and risk stratification in the West Virginian population. Int J Med Sci 2016; 13(1): 25-38.
[http://dx.doi.org/10.7150/ijms.13800] [PMID: 26816492]
[11]
Basarir G, Ozcabi B, Aksu Sayman O, Ozturkmen Akay H, Yildiz FM. Evaluation of clinical, endocrine and metabolic findings in obese children with and without hepatosteatosis. J Pediatr Endocrinol Metab 2021; 34(9): 1081-7.
[http://dx.doi.org/10.1515/jpem-2021-0034] [PMID: 34142516]
[12]
Moodi M, Firoozabadi MD, Kazemi T, et al. Birjand Longitudinal Aging Study (BLAS): The objectives, study protocol and design (wave I: Baseline data gathering). J Diabetes Metab Disord 2020; 19(1): 551-9.
[http://dx.doi.org/10.1007/s40200-020-00504-5] [PMID: 32550207]
[13]
Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: An American heart association/national heart, lung, and blood institute scientific statement. Circulation 2005; 112(17): 2735-52.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.105.169404] [PMID: 16157765]
[14]
Kalan Farmanfarma K, Kaykhaei MA, Adineh HA, Mohammadi M, Dabiri S, Ansari-Moghaddam A. Prevalence of metabolic syndrome in Iran: A meta-analysis of 69 studies. Diabetes Metab Syndr 2019; 13(1): 792-9.
[http://dx.doi.org/10.1016/j.dsx.2018.11.055] [PMID: 30641809]
[15]
Gu Z, Zhu P, Wang Q, et al. Obesity and lipid-related parameters for predicting metabolic syndrome in Chinese elderly population. Lipids Health Dis 2018; 17(1): 289.
[http://dx.doi.org/10.1186/s12944-018-0927-x] [PMID: 30572889]
[16]
Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study. Lancet 2004; 364(9438): 937-52.
[http://dx.doi.org/10.1016/S0140-6736(04)17018-9] [PMID: 15364185]
[17]
Ghargerechi R, Razzaghy Azar M. Prevalence of metabolic syndrome in obese children and adolescents dolescents. Med J Tabriz Uni Med Sciences Health Services 2010; 32(3): 57-61.
[18]
Ostovar R, Kiani F, Sayehmiri F, Yasemi M, Mohsenzadeh Y, Mohsenzadeh Y. Prevalence of metabolic syndrome in Iran: A meta-analysis. Electron Physician 2017; 9(10): 5402-18.
[http://dx.doi.org/10.19082/5402] [PMID: 29238477]
[19]
Sarrafzadegan N, Kelishadi R, Baghaei A, et al. Metabolic syndrome: An emerging public health problem in Iranian women: Isfahan healthy heart program. Int J Cardiol 2008; 131(1): 90-6.
[http://dx.doi.org/10.1016/j.ijcard.2007.10.049] [PMID: 18190978]
[20]
Wang F, Wu S, Song Y, et al. Waist circumference, body mass index and waist to hip ratio for prediction of the metabolic syndrome in Chinese. Nutr Metab Cardiovasc Dis 2009; 19(8): 542-7.
[http://dx.doi.org/10.1016/j.numecd.2008.11.006] [PMID: 19188050]
[21]
Hosseini-Esfahani F, Bahadoran Z, Moslehi N, et al. Metabolic syndrome: Findings from 20 years of the tehran lipid and glucose study. Int J Endocrinol Metab 2018; 16(4) (Suppl.).e84771
[http://dx.doi.org/10.5812/ijem.84771] [PMID: 30584438]
[22]
Mirzazadeh A, Sadeghirad B, Haghdoost AA, Bahreini F. The prevalence of obesity in Iran in recent decade; a systematic review and meta-analysis study. Iran J Public Health 2009; 38: 1-11.
[23]
Djalalinia S, Saeedi Moghaddam S, Sheidaei A, et al. Patterns of obesity and overweight in the Iranian population: Findings of STEPs 2016. Front Endocrinol (Lausanne) 2020; 11: 42.
[http://dx.doi.org/10.3389/fendo.2020.00042] [PMID: 32174887]
[24]
Ormazabal V, Nair S, Elfeky O, Aguayo C, Salomon C, Zuñiga FA. Association between insulin resistance and the development of cardiovascular disease. Cardiovasc Diabetol 2018; 17(1): 122.
[http://dx.doi.org/10.1186/s12933-018-0762-4] [PMID: 30170598]
[25]
Gasevic D, Frohlich J, Mancini GJ, Lear SA. Clinical usefulness of lipid ratios to identify men and women with metabolic syndrome: A cross-sectional study. Lipids Health Dis 2014; 13(1): 159.
[http://dx.doi.org/10.1186/1476-511X-13-159] [PMID: 25300321]
[26]
Chen BD, Yang YN, Ma YT, et al. Waist-to-Height ratio and triglycerides/high-density lipoprotein cholesterol were the optimal predictors of metabolic syndrome in uighur men and women in Xinjiang, China. Metab Syndr Relat Disord 2015; 13(5): 214-20.
[http://dx.doi.org/10.1089/met.2014.0146] [PMID: 25781351]
[27]
Patil R, Sood GK. Non-alcoholic fatty liver disease and cardiovascular risk. World J Gastrointest Pathophysiol 2017; 8(2): 51-8.
[http://dx.doi.org/10.4291/wjgp.v8.i2.51] [PMID: 28573067]
[28]
Liu C-F, Zhou W-N, Lu Z, Wang X-T, Qiu ZH. The associations between liver enzymes and the risk of metabolic syndrome in the elderly. Exp Gerontol 2018; 106: 132-6.
[http://dx.doi.org/10.1016/j.exger.2018.02.026] [PMID: 29499373]
[29]
DeFina LF, Vega GL, Leonard D, Grundy SM. Fasting glucose, obesity, and metabolic syndrome as predictors of type 2 diabetes: The Cooper Center Longitudinal Study. J Investig Med 2012; 60(8): 1164-8.
[http://dx.doi.org/10.2310/JIM.0b013e318275656a] [PMID: 23111652]
[30]
Leoncini G, Ratto E, Viazzi F, et al. Metabolic syndrome is associated with early signs of organ damage in nondiabetic, hypertensive patients. J Intern Med 2005; 257(5): 454-60.
[http://dx.doi.org/10.1111/j.1365-2796.2005.01468.x] [PMID: 15836662]
[31]
Scuteri A, Najjar SS, Muller DC, et al. Metabolic syndrome amplifies the age-associated increases in vascular thickness and stiffness. J Am Coll Cardiol 2004; 43(8): 1388-95.
[http://dx.doi.org/10.1016/j.jacc.2003.10.061] [PMID: 15093872]
[32]
Ratto E, Leoncini G, Viazzi F, et al. Metabolic syndrome and cardiovascular risk in primary hypertension. J Am Soc Nephrol 2006; 17(4) (Suppl. 2): S120-2.
[http://dx.doi.org/10.1681/ASN.2005121328] [PMID: 16565234]

Rights & Permissions Print Cite
Article Metrics
1
© 2024 Bentham Science Publishers | Privacy Policy